It is striking that more events were noted among the fasting patients despite having significantly better kidney functions than the nonfasting patients; this underscores the risk of fasting on cardiovascular events that may supersede the risk of lower kidney functions.
Recurrent kidney stone formers have a significantly lower level of kidney function and a markedly higher prevalence of CKD than age- and gender-matched control subjects.
We hypothesized that lower levels of kidney function would be associated with increased rates of death, hospitalization, and bleeding in this clopidogrel-treated cohort following ACS.
Lower levels of kidney function were associated with higher rates of death, AMI hospitalization, and major bleeding among patients taking clopidogrel after hospitalization for ACS.
In the present study, we found a significantly lower level of kidney function and a markedly higher prevalence of CKD in patients with recurrent kidney stone disease than in age- and gender-matched control subjects.
In summary, among patients hospitalized with ACS and treated with clopidogrel, lower levels of kidney function were associated with a greater risk of death, hospitalization for AMI, and major bleeding.
One of the most claimed reasons for long-term worse outcomes after AKI is incomplete renal recovery [ 12, 15], which covers a spectrum from patients whose glomerular filtration rate is discrete lower than their kidney function was beforehand to patients who remain dependent on dialysis.
Others have observed a progressive increase in both minor and major bleeding events with lower levels of kidney function for patients during hospitalization for ACS [ 28] or in the course of follow up thereafter while on antiplatelet therapies [ 17, 18, 27].
To inform future effectiveness studies aimed at preventing CKD among high-risk African Americans, we examined participants' views on specific components of the DASH diet which has been associated with lower risk of kidney function decline [ 11] and other favorable health outcomes [ 30– 30].
Bienaimé et al. also reported that patients with lower serum total 25(OH D concentrations at 3 months after transplantation exhibited lower kidney allograft function at 1 year after transplantation and had higher risk of the progression of interstitial fibrosis and tubular atrophy [ 40].
The apparent improvement in kidney function after lowering the adenine concentration, as indicated by a decline in blood urea and PTH levels, suggests at least a partial reversibility of renal impairment.
